SSOs that modulate the IR-A:IR-B mRNA ratio are a significant recent advancement in IR research (19, 44); however, reducing IR pre-mRNA splicing to IR-A results in an increase in IR-B mRNA, which correlates with worse patient outcomes in breast cancer (3). The gene discussed is PPIB; the disease is breast cancer.